
Astec Lifesciences Ltd Technical Momentum Shifts Amid Mixed Market Signals
2026-05-20 08:02:26Astec Lifesciences Ltd, a small-cap player in the Pesticides & Agrochemicals sector, has exhibited a subtle shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. Despite a recent day decline of 1.59%, the stock’s weekly and monthly technical indicators reveal a complex interplay of bullish and bearish signals, warranting a nuanced analysis for investors navigating this evolving landscape.
Read More
Astec Lifesciences Ltd Sees Technical Momentum Shift Amid Mixed Market Signals
2026-05-19 08:03:23Astec Lifesciences Ltd, a small-cap player in the Pesticides & Agrochemicals sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals. The stock surged 10.90% on 19 May 2026, closing at ₹750.65, marking a significant rebound from its previous close of ₹676.90. This movement comes amid a broader sideways technical trend, with key indicators such as MACD and Bollinger Bands signalling mixed sentiments across weekly and monthly timeframes.
Read MoreAre Astec Lifesciences Ltd latest results good or bad?
2026-04-28 19:13:57Astec Lifesciences Ltd's latest financial results for the quarter ending March 2026 reflect a complex operational landscape. The company reported net sales of ₹158.62 crores, marking a year-on-year growth of 32.70% compared to ₹119.53 crores in the same quarter last year. This growth is notable as it represents the highest quarterly revenue in recent periods, indicating a return of revenue growth momentum. Despite the positive sales figures, Astec experienced a net loss of ₹7.76 crores in Q4 FY26, which, while an improvement from previous quarters, underscores ongoing challenges in achieving profitability. The company's operating profit before depreciation, interest, tax, and other income (PBDIT) turned positive at ₹9.16 crores, a significant increase from ₹3.99 crores in Q3 FY26, with an operating margin of 5.77%, up from 3.20% in the prior quarter. However, these margins remain considerably lower than hi...
Read MoreAstec Lifesciences Gains 10.13%: Key Technical Shifts and Intraday Surges Shape the Week
2026-04-18 17:00:51Key Events This Week 13 Apr: Mixed technical signals amid a strong daily rally 16 Apr: Intraday high with 9.07% surge 17 Apr: Week closes at Rs.726.50 (-3.06% on day) Week OpenRs.659.70 Week CloseRs.726.50+10.13% Week Hi...
Read More
Astec Lifesciences Ltd Surges 9.07% to Day's High of Rs 715.9 — Outperforms Sector by 8.02 Percentage Points
2026-04-16 09:30:49The Sensex advanced 0.73% on 16 Apr 2026, yet Astec Lifesciences Ltd outpaced the broader market with a 9.07% gain, touching an intraday high of Rs 715.9. This 8.02-percentage-point outperformance over its sector signals a distinctly stock-specific rally rather than a market-wide lift.
Read More
Astec Lifesciences Ltd Sees Mixed Technical Signals Amid Strong Daily Rally
2026-04-13 08:02:09Astec Lifesciences Ltd has witnessed a notable shift in its technical momentum, with recent price action and indicator signals reflecting a complex interplay of bullish and bearish forces. The stock surged 17.7% in a single day to close at ₹659.70, marking a significant rebound from its previous close of ₹560.45. However, despite this sharp intraday gain, the broader technical landscape remains mixed, with several key indicators signalling caution for investors in this small-cap pesticide and agrochemical player.
Read MoreAstec Lifesciences Surges 21.07% in a Week: Key Drivers Behind the Rally
2026-04-11 17:01:35Key Events This Week 6 Apr: Week opens at Rs.544.90 7 Apr: Minor dip of 0.55% amid broader market gains 8 Apr: Recovery with 1.94% gain, Sensex surges 3.88% 9 Apr: Continued gains of 1.46% despite Sensex dip 10 Apr: Astec Lifesciences hits upper circuit with 18.21% surge closing at Rs.659.70 Week OpenRs.544.90 <div class="stat...
Read More
Astec Lifesciences Ltd is Rated Strong Sell
2026-04-11 10:10:25Astec Lifesciences Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 23 September 2024. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 11 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
Read More
Astec Lifesciences Ltd Locks at Upper Circuit With 18.2% Gain — Buyers Queue, Sellers Absent
2026-04-10 15:00:06At Rs 672, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Astec Lifesciences Ltd locked at its upper circuit of 20% on 10 Apr 2026, with buyers queuing and no sellers willing to part with shares.
Read MoreAnnouncement under Regulation 30 (LODR)-Change in Management
05-Jun-2026 | Source : BSEPlease find enclosed intimation.
Announcement under Regulation 30 (LODR)-Newspaper Publication
03-Jun-2026 | Source : BSEPlease find enclosed Newspaper publication.
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
02-Jun-2026 | Source : BSEPlease find enclosed intimation regarding Postal Ballot notice.
Corporate Actions
No Upcoming Board Meetings
Astec Lifesciences Ltd has declared 15% dividend, ex-date: 21 Jul 23
No Splits history available
No Bonus history available
Astec Lifesciences Ltd has announced 1:7 rights issue, ex-date: 04 Jul 25